Pharmaceutical Technology Europe, Jun 1, 2010 - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

Pharmaceutical Technology Europe, Jun 1, 2010
Special Feature
Tabletting: the issues facing today's manufacturers
Compressed tablets are the most popular solid dosage form and, despite having been used for many years, still offer numerous advantages.
Tablet compression: changing trends, more demands
By Jan Vogeleer
The market for tablet compression technology and the demands placed on equipment manufacturers have changed quite significantly in recent years.
Tabletting equipment: common problems and how to avoid them
By Trevor Higgins
The most common cause of equipment problems and malfunctions is misuse or improper handling and transportation, which often leads to tablet punch damage.
Granulation: evolving slowly but surely
By Guia Bertuzzi
Granulation is the most crucial step in the manufacture of solid dosage forms.
Drying: moving from batch to continuous processes
By Griet Van Vaerenbergh
The requirements of a granule drying process haven't really changed much in recent years.
Interview
Working towards greener manufacturing
PTE spoke with Dr. Peter Dunn, Global Green Chemistry Lead at Pfizer, about the changes that yield significant energy efficiencies and the strategy behind the company's green chemistry program.
Manufacturing
Assessing environmental risk of pharmaceuticals
By D.F. de Roode
An environmental risk assessment (ERA) is now required for all new pharmaceutical product marketing authorisation applications. The author outlines the steps to this procedure.
Regulation
Detecting GMP failures
By Wolfgang Schmitt
An effective quality management system will identify the root cause of non-conformances and put measures in place to ensure that they do not recur, but is the pharmaceutical industry choosing the right methods to make sure this happens?
Information Technology
Data sharing more efficient with purpose-built LIMS
By Gary Walz
A laboratory information system (LIMS) is a key tool in facilitating communication between a pharmaceutical company and its outsourcing partners; however, most LIMS require extensive customisation before they can be used in the pharmaceutical industry.
Ask the Expert
The importance of powder characterization
By Tim Freeman
How effective powder characterization can lead to better powder understanding and control.
Outsourcing Review
EU debt crisis adds uncertainty for contract services
By Jim Miller
Having barely begun recovering from the economic slump that began in 2008, the contract services industry must now face the consequences of the debt crisis in Europe, which will include reduced bio/pharmaceutical expenditure by governments.
Spotlight
German pharma's hopes and fears
By Faiz Kermani
Despite being a historically strong performer in the pharmaceutical arena, Germany is now underperforming compared with the growth of other European markets.
Talking Point
QPSHARE: a new way to share audits
By Bernd Renger
Shared audits of suppliers offer several advantages, but networking to conduct such an audit can be challenging.
News
News
When will personalised medicine deliver on its promise? and Europe's IP system trails behind the US
Editor's Comment
This is your chance to get involved
By Fedra Pavlou
Have you ever come across a new technology, process or problem in your profession and wanted to tell others or learn more about it?

ADVERTISEMENT

LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
FDASIA was signed into law two years ago. Where has the most progress been made in implementation?
Reducing drug shortages
Breakthrough designations
Protecting the supply chain
Expedited reviews of drug submissions
More stakeholder involvement
Reducing drug shortages
32%
Breakthrough designations
11%
Protecting the supply chain
37%
Expedited reviews of drug submissions
11%
More stakeholder involvement
11%
View Results
Jim Miller Outsourcing Outlook Jim Miller Health Systems Raise the Bar on Reimbursing New Drugs
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerThe Mainstreaming of Continuous Flow API Synthesis
Jill Wechsler Regulatory Watch Jill Wechsler Industry Seeks Clearer Standards for Track and Trace
Siegfried Schmitt Ask the Expert Siegfried SchmittData Integrity
Click here